Literature DB >> 11331334

Strategies to manage the adverse effects of oral morphine: an evidence-based report.

N Cherny1, C Ripamonti, J Pereira, C Davis, M Fallon, H McQuay, S Mercadante, G Pasternak, V Ventafridda.   

Abstract

Successful pain management with opioids requires that adequate analgesia be achieved without excessive adverse effects. By these criteria, a substantial minority of patients treated with oral morphine (10% to 30%) do not have a successful outcome because of (1) excessive adverse effects, (2) inadequate analgesia, or (3) a combination of both excessive adverse effects along with inadequate analgesia. The management of excessive adverse effects remains a major clinical challenge. Multiple approaches have been described to address this problem. The clinical challenge of selecting the best option is enhanced by the lack of definitive, evidence-based comparative data. Indeed, this aspect of opioid therapeutics has become a focus of substantial controversy. This study presents evidence-based recommendations for clinical-practice formulated by an Expert Working Group of the European Association of Palliative Care (EAPC) Research NETWORK: These recommendations highlight the need for careful evaluation to distinguish between morphine adverse effects from comorbidity, dehydration, or drug interactions, and initial consideration of dose reduction (possibly by the addition of a co analgesic). If side effects persist, the clinician should consider options of symptomatic management of the adverse effect, opioid rotation, or switching route of systemic administration. The approaches are described and guidelines are provided to aid in selecting between therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331334     DOI: 10.1200/JCO.2001.19.9.2542

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  125 in total

1.  The importance of clinical practice guidelines (CPGs) for the quality and development of supportive care in Central and Eastern European (CEE) countries.

Authors:  Snezana Bosnjak
Journal:  Support Care Cancer       Date:  2003-10-15       Impact factor: 3.603

Review 2.  Management of opioid-induced bowel dysfunction in cancer patients.

Authors:  Antonio Cesar Tamayo; Paola Andrea Diaz-Zuluaga
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

3.  [Strong opioids and constipation].

Authors:  A Schwarzer; F Nauck; E Klaschik
Journal:  Schmerz       Date:  2005-06       Impact factor: 1.107

4.  Counseling patients on side effects and driving when starting opioids #248.

Authors:  Randall E Schisler; Hunter Groninger; Drew A Rosielle
Journal:  J Palliat Med       Date:  2012-04       Impact factor: 2.947

Review 5.  Management of cancer pain.

Authors:  Sebastiano Mercadante
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

6.  Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice.

Authors:  Juan A Virizuela; Yolanda Escobar; Javier Cassinello; Pablo Borrega
Journal:  Clin Transl Oncol       Date:  2012-07       Impact factor: 3.405

Review 7.  Contribution to variability in response to opioids.

Authors:  Geoffrey W Hanks; Colette Reid
Journal:  Support Care Cancer       Date:  2004-12-10       Impact factor: 3.603

8.  Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene.

Authors:  Jin Xu; Mingming Xu; Yasmin L Hurd; Gavril W Pasternak; Ying-Xian Pan
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

Review 9.  Analgesia for patients with advanced disease: 2.

Authors:  E J Hall; N P Sykes
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401

Review 10.  Management of breakthrough pain in patients with cancer.

Authors:  Leeroy William; Rod Macleod
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.